Evidence map›Paper›PMID 35200586›Full record

ArticleCurrent oncology (Toronto, Ont.)2022

Assessing Choroidal Nevi, Melanomas and Indeterminate Melanocytic Lesions Using Multimodal Imaging-A Retrospective Chart Review.

Fredy Geiger, Sadiq Said, Anahita Bajka, Mario Damiano Toro, Maximilian Robert Justus Wiest, Marc Stahel, Daniel Barthelmes, Sandrine Anne Zweifel

Open access · goldAbstract read
In one paragraph

Article in Current oncology (Toronto, Ont.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Multispectral Fundus Photography of Choroidal Nevi with Trans-Palpebral Illumination.medRxiv : the preprint server for health sciences · 2024
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 3 countries.

Fredy GeigerDepartment of Ophthalmology, University Hospital of Zurich, 8091 Zurich, Switzerland.
Sadiq SaidDepartment of Ophthalmology, University Hospital of Zurich, 8091 Zurich, Switzerland.ORCID 0000-0003-2037-4766
Anahita BajkaDepartment of Ophthalmology, University Hospital of Zurich, 8091 Zurich, Switzerland.
Mario Damiano ToroChair and Department of General and Pediatric Ophthalmology, Medical University of Lublin, 20079 Lublin, Poland.ORCID 0000-0001-7152-2613
Maximilian Robert Justus WiestDepartment of Ophthalmology, University Hospital of Zurich, 8091 Zurich, Switzerland.ORCID 0000-0002-7561-1805
Marc StahelDepartment of Ophthalmology, University Hospital of Zurich, 8091 Zurich, Switzerland.
Daniel BarthelmesDepartment of Ophthalmology, University Hospital of Zurich, 8091 Zurich, Switzerland.ORCID 0000-0002-5431-4991
Sandrine Anne ZweifelDepartment of Ophthalmology, University Hospital of Zurich, 8091 Zurich, Switzerland.ORCID 0000-0001-7431-1774
University of Zurich · CHMedical University of Lublin · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Using multimodal imaging, the literature proposed the following risk factors for choroidal nevus growth into melanoma: increased tumor thickness, subretinal fluid, decreased visual acuity, presence of orange pigment, ultrasound acoustic hollowness, and increased tumor diameter. This study investigated the presence of the mentioned risk factors in choroidal nevi, choroidal melanomas, and indeterminate choroidal melanocytic lesions. This retrospective, single-center chart review assessed choroidal melanocytic tumors with multimodal imaging. We defined our primary outcome as the cumulative presence of mentioned risk factors. Further, we evaluated various optical coherence tomography (OCT), ultrasound, and autofluorescence findings. We analyzed 51 tumors from 49 patients during the period from April 2008 to June 2021. The median (IQR) age was 64.0 (56.0 to 70.5) years, with 23 of 49 (46.9%) patients being female. The follow-up time for all tumors was median (IQR) 25.0 (12.0 to 39.0) months. The choroidal nevi had a median (range) risk score of 0.0 (0.0 to 3.0), and the choroidal melanoma of 5.0 (3.0 to 6.0), with statistically significant different ratings (

Indexed as

MelanomaNevus, PigmentedSkin NeoplasmsAgedFemaleHumansMiddle AgedMultimodal ImagingRetrospective Studieschoroidal nevuschoroidal tumorsmelanomamultimodal imagingophthalmic oncologyoptical coherence tomography

Identifiers

PMID35200586
PMCPMC8870916
OpenAlexW4212907521

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.